Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates

Significant progress has already been made in development and testing of SARS-CoV-2 vaccines, and Phase III clinical trials have begun for 6 novel vaccine candidates to date. These Phase III trials seek to demonstrate direct benefits of a vaccine on vaccine recipients. However, vaccination is also k...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Gallagher, Molly E., Sieben, Andrew J., Nelson, Kristin N., Kraay, Alicia N. M., Lopman, Ben, Handel, Andreas, Koelle, Katia
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430602/
https://ncbi.nlm.nih.gov/pubmed/32817958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.07.20170456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars